These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 20507313

  • 1. Monoclonal gammopathy of undetermined significance: a consensus statement.
    Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA.
    Br J Haematol; 2010 Jul; 150(1):28-38. PubMed ID: 20507313
    [Abstract] [Full Text] [Related]

  • 2. Emerging concepts in monoclonal gammopathy of undetermined significance.
    Freytes CO.
    Bol Asoc Med P R; 2010 Jul; 102(4):43-6. PubMed ID: 21766546
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Best Pract Res Clin Haematol; 2005 Jul; 18(4):689-707. PubMed ID: 16026745
    [Abstract] [Full Text] [Related]

  • 4. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
    Jerez A, Ortuño FJ, Osma Mdel M, Español I, González AD, Roldán V, de Arriba F, Vicente V.
    Ann Med; 2009 Jul; 41(7):547-58. PubMed ID: 19634064
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal gammopathy of undetermined significance.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
    Berenson JR, Yellin O.
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):311-5. PubMed ID: 19717382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
    Simon Z, Sipka S, Gergely L, Csípö I, Illés A.
    Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S, Kyle RA, Dyck PJ.
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [Abstract] [Full Text] [Related]

  • 15. A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.
    Berenson JR, Yellin O, Quiery A, Brady J, Patel R, Wong SF, Colbourn D, Gravenor D, Tiffany N, Shamasunder HK, Waterman B, Melamed K, Wirtschafter E.
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):336-41. PubMed ID: 21816371
    [Abstract] [Full Text] [Related]

  • 16. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL, Sarid R.
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
    Klincová M, Sandecká V, Mikuláiová A, Radocha J, Maisnar V, Hájek R.
    Klin Onkol; 2011 Mar; 24 Suppl():S14-7. PubMed ID: 21923058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.